Search research articles
Contact Us
Filters
Showing results (31-40 of 194) with videos related to
Page
of 20
Sort By:
Journal of Alzheimer'S Disease : JAD
|
June 30, 2025
Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials
Guoqiao Wang, Tianle Chen, John O'Gorman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Jorge J Llibre-Guerra, Jin Zhou, Lon S S Schneider, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Jin Zhou, Erica Andreozzi, Jorge J Llibre-Guerra, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
September 14, 2019
Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
Guoqiao Wang, Andrew J Aschenbrenner, Yan Li, et al.
Archives of Neurology
|
May 11, 2011
Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects
Mary M Machulda, David T Jones, Prashanthi Vemuri, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
August 27, 2023
"And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure
Jeong Eun Kim, Lisa K Tamres, Staci L Orbell, et al.
Neurology
|
September 29, 2012
Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study
Oscar L Lopez, James T Becker, Yue-Fang Chang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 13, 2024
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence
Paul Aisen, Randall J Bateman, Damian Crowther, et al.
Stroke
|
December 17, 2009
Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke
Marcella A Wozniak, Steven J Kittner, Stanley Tuhrim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Kristin R Wildsmith, Arnaud Charil, Tammie L S Benzinger, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 194) with videos related to
Sort By:
Page
of 20
Journal of Alzheimer'S Disease : JAD
|
June 30, 2025
Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials
Guoqiao Wang, Tianle Chen, John O'Gorman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Jorge J Llibre-Guerra, Jin Zhou, Lon S S Schneider, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Jin Zhou, Erica Andreozzi, Jorge J Llibre-Guerra, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
September 14, 2019
Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
Guoqiao Wang, Andrew J Aschenbrenner, Yan Li, et al.
Archives of Neurology
|
May 11, 2011
Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects
Mary M Machulda, David T Jones, Prashanthi Vemuri, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
August 27, 2023
"And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure
Jeong Eun Kim, Lisa K Tamres, Staci L Orbell, et al.
Neurology
|
September 29, 2012
Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study
Oscar L Lopez, James T Becker, Yue-Fang Chang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 13, 2024
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence
Paul Aisen, Randall J Bateman, Damian Crowther, et al.
Stroke
|
December 17, 2009
Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke
Marcella A Wozniak, Steven J Kittner, Stanley Tuhrim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Kristin R Wildsmith, Arnaud Charil, Tammie L S Benzinger, et al.
Page
of 20